<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00535743</url>
  </required_header>
  <id_info>
    <org_study_id>P05944</org_study_id>
    <secondary_id>19.4.206</secondary_id>
    <secondary_id>MK-8616-024</secondary_id>
    <nct_id>NCT00535743</nct_id>
  </id_info>
  <brief_title>Dose-Finding Trial With Sugammadex Administered at 3 and 15 Minutes After 1.0 and 1.2 mg/kg Rocuronium Bromide in Participants of ASA Class 1-3 (P05944; MK-8616-024)</brief_title>
  <official_title>A Multi-Center, Randomized, Safety Assessor-Blinded, Placebo- Controlled, Phase II, Parallel Dose-Finding Trial in Subjects of ASA 1-3 to Assess the Efficacy and Safety of 5 Doses of Sugammadex Administered at 3 and 15 Minutes After Administration of 1.0 and 1.2 mg/kg Rocuronium Bromide</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this trial was to explore the dose-response relation of sugammadex (Org
      25969; MK-8616) administered for the reversal of neuromuscular blockade (NMB) at 3 and 15
      minutes following administration of 1.0 and 1.2 mg/kg of Esmeron® (rocuronium) in
      participants receiving surgery, classified as American Society of Anesthesiologists (ASA)
      class 1 (otherwise normal, healthy participant), class 2 (participant with mild systemic
      disease), or class 3 (participant with a severe systemic disease that limits activity, but is
      not incapacitating).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the United States, the highest dose recommended in the package insert of Zemuron® (i.e.
      the trade name for Esmeron® in the US) is 1.2 mg/kg whereas in Europe it is 1.0 mg/kg. For
      both doses, dose recommendations for reversal with sugammadex were to be found. Hence, the
      present trial was set up to explore the dose-response relation of sugammadex given as an NMB
      reversal agent at 3 and 15 minutes following administration of 1.0 and 1.2 mg/kg of Esmeron®
      in subjects of ASA 1 to 3. The sub-investigator who performed any subjective safety
      assessments after anesthesia was to be remained blinded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 4, 2004</start_date>
  <completion_date type="Actual">July 20, 2004</completion_date>
  <primary_completion_date type="Actual">July 20, 2004</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Time From Start of Study Treatment Administration to Recovery of the T4/T1 Ratio to 0.9</measure>
    <time_frame>Up to 240 minutes following administration of study treatment</time_frame>
    <description>Mean time from start of study treatment administration to recovery of participant T4/T1 ratio to 0.9 was assessed through the repeated application (every 15 seconds) of an electrical stimulation protocol. Specifically, 4 electrical stimulations were applied to the ulnar nerve and the magnitude of the twitch response of the adductor pollicis muscle (i.e. thumb twitch response) was assessed. With T4 and T1 referring to the respective magnitude of the fourth and first thumb twitch during nerve stimulation, the T4/T1 ratio indicates the current degree of neuromuscular blockade (NMB) present in the participant as a decimal from 0 (loss of T4 twitch) to 1 (no NMB). Further, reduced recovery time of the T4/T1 ratio to 0.9 indicates faster recovery from NMB. Summary data, originally presented in the format of units &quot;minutes:seconds&quot; (mm:ss), was reformatted to be presented in the single unit of &quot;minutes&quot; (min).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Time From Start of Study Treatment Administration to Recovery of the T4/T1 Ratio to 0.8</measure>
    <time_frame>Up to 200 minutes following administration of study treatment</time_frame>
    <description>Mean time from start of study treatment administration to recovery of participant T4/T1 ratio to 0.8 was assessed through the repeated application (every 15 seconds) of an electrical stimulation protocol. Specifically, 4 electrical stimulations were applied to the ulnar nerve and the magnitude of the twitch response of the adductor pollicis muscle (i.e. thumb twitch response) was assessed. With T4 and T1 referring to the respective magnitude of the fourth and first thumb twitch during nerve stimulation, the T4/T1 ratio indicates the current degree of NMB present in the participant as a decimal from 0 (loss of T4 twitch) to 1 (no NMB). Further, reduced recovery time of the T4/T1 ratio to 0.8 indicates faster recovery from NMB. Summary data, originally presented in the format of units &quot;minutes:seconds&quot; (mm:ss), was reformatted to be presented in the single unit of &quot;minutes&quot; (min).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Time From Start of Study Treatment Administration to Recovery of the T4/T1 Ratio to 0.7</measure>
    <time_frame>Up to 180 minutes following administration of study treatment</time_frame>
    <description>Mean time from start of study treatment administration to recovery of participant T4/T1 ratio to 0.7 was assessed through the repeated application (every 15 seconds) of an electrical stimulation protocol. Specifically, 4 electrical stimulations were applied to the ulnar nerve and the magnitude of the twitch response of the adductor pollicis muscle (i.e. thumb twitch response) was assessed. With T4 and T1 referring to the respective magnitude of the fourth and first thumb twitch during nerve stimulation, the T4/T1 ratio indicates the current degree of NMB present in the participant as a decimal from 0 (loss of T4 twitch) to 1 (no NMB). Further, reduced recovery time of the T4/T1 ratio to 0.7 indicates faster recovery from NMB. Summary data, originally presented in the format of units &quot;minutes:seconds&quot; (mm:ss), was reformatted to be presented in the single unit of &quot;minutes&quot; (min).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Experiencing an Adverse Event</measure>
    <time_frame>Up to 7 days following administration of study treatment</time_frame>
    <description>The number of participants experiencing an adverse event (AE) was assessed. An AE was defined as any untoward medical occurrence in a participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of an investigational product, whether or not considered related to the investigational product.</description>
  </secondary_outcome>
  <number_of_arms>24</number_of_arms>
  <enrollment type="Actual">174</enrollment>
  <condition>Anesthesia, General</condition>
  <arm_group>
    <arm_group_label>Arm A. Placebo; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (single intravenous (IV) bolus) administered 3 minutes (min) after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm B. 2 mg/kg sugammadex; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (2 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm C. 4 mg/kg sugammadex; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (4 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm D. 8 mg/kg sugammadex; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (8 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm E. 12 mg/kg sugammadex; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (12 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm F. 16 mg/kg sugammadex; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (16 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm G. Placebo; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (single intravenous (IV) bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm H. 2 mg/kg sugammadex; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (2 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm I. 4 mg/kg sugammadex; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (4 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm J. 8 mg/kg sugammadex; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (8 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm K. 12 mg/kg sugammadex; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (12 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm L. 16 mg/kg sugammadex; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (16 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm M. Placebo; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm N. 2 mg/kg sugammadex; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (2 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm O. 4 mg/kg sugammadex; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (4 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm P. 8 mg/kg sugammadex; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (8 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm Q. 12 mg/kg sugammadex; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (12 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm R. 16 mg/kg sugammadex; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (16 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm S. Placebo; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm T. 2 mg/kg sugammadex; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (2 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm U. 4 mg/kg sugammadex; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (4 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm V. 8 mg/kg sugammadex; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (8 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm W. 12 mg/kg sugammadex; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (12 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm X. 16 mg/kg sugammadex; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sugammadex (16 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sugammadex</intervention_name>
    <description>Sugammadex administered as a fast IV bolus dose (within 30 seconds) at 3 or 15 minutes following administration of Esmeron®, dosed at 2, 4, 8, 12 or 16 mg/kg according to participant actual body weight.</description>
    <arm_group_label>Arm B. 2 mg/kg sugammadex; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm C. 4 mg/kg sugammadex; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm D. 8 mg/kg sugammadex; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm E. 12 mg/kg sugammadex; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm F. 16 mg/kg sugammadex; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm H. 2 mg/kg sugammadex; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm I. 4 mg/kg sugammadex; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm J. 8 mg/kg sugammadex; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm K. 12 mg/kg sugammadex; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm L. 16 mg/kg sugammadex; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm N. 2 mg/kg sugammadex; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm O. 4 mg/kg sugammadex; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm P. 8 mg/kg sugammadex; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm Q. 12 mg/kg sugammadex; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm R. 16 mg/kg sugammadex; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm T. 2 mg/kg sugammadex; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm U. 4 mg/kg sugammadex; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm V. 8 mg/kg sugammadex; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm W. 12 mg/kg sugammadex; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm X. 16 mg/kg sugammadex; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <other_name>Org 25969</other_name>
    <other_name>MK-8616</other_name>
    <other_name>BRIDION®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>0.9% NaCl administered as a fast IV bolus dose (within 30 seconds) at 3 or 15 minutes following administration of Esmeron®,</description>
    <arm_group_label>Arm A. Placebo; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm G. Placebo; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm M. Placebo; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm S. Placebo; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <other_name>NaCl 0.9%</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Esmeron®</intervention_name>
    <description>Esmeron® administered at 1 or 1.2 mg/kg as a fast IV bolus (within 10 seconds), dosed according to participant actual body weight.</description>
    <arm_group_label>Arm A. Placebo; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm B. 2 mg/kg sugammadex; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm C. 4 mg/kg sugammadex; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm D. 8 mg/kg sugammadex; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm E. 12 mg/kg sugammadex; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm F. 16 mg/kg sugammadex; 3 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm G. Placebo; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm H. 2 mg/kg sugammadex; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm I. 4 mg/kg sugammadex; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm J. 8 mg/kg sugammadex; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm K. 12 mg/kg sugammadex; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm L. 16 mg/kg sugammadex; 15 min after 1 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm M. Placebo; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm N. 2 mg/kg sugammadex; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm O. 4 mg/kg sugammadex; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm P. 8 mg/kg sugammadex; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm Q. 12 mg/kg sugammadex; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm R. 16 mg/kg sugammadex; 3 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm S. Placebo; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm T. 2 mg/kg sugammadex; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm U. 4 mg/kg sugammadex; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm V. 8 mg/kg sugammadex; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm W. 12 mg/kg sugammadex; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <arm_group_label>Arm X. 16 mg/kg sugammadex; 15 min after 1.2 mg/kg Esmeron®</arm_group_label>
    <other_name>Zemuron®</other_name>
    <other_name>Rocuronium bromide</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants of ASA class 1 - 3, above or equal to the age of 18 years;

          -  Participants scheduled for surgical procedures with an anticipated duration of
             anesthesia of at least 120 minutes, without further need for muscle relaxation other
             than for intubation;

          -  Participants scheduled for surgical procedures in supine position;

          -  Participants who had given written informed consent.

        Exclusion Criteria:

          -  Participants in whom a difficult intubation because of anatomical malformations was
             expected;

          -  Participants known or suspected to have neuromuscular disorders impairing
             neuromuscular blocking and/or significant renal dysfunction;

          -  Participants known or suspected to have a (family) history of malignant hyperthermia;

          -  Participants known or suspected to have an allergy to narcotics, muscle relaxants or
             other medication used during general anesthesia;

          -  Participants receiving medication known to interfere with neuromuscular blocking
             agents, such as anticonvulsants and Mg^2+;

          -  Participants who had already participated in this trial;

          -  Participants who had participated in another clinical trial, not pre-approved by the
             Sponsor, within 30 days of entering into this trial;

          -  Female participants who were pregnant: in females, pregnancy was to be excluded both
             from medical history and by a human chorionic gonadotropin (hCG) test within 24 hours
             before surgery except in females who were not of childbearing potential, i.e. at least
             2 years menopausal or who had undergone tubal ligation or an hysterectomy;

          -  Female participants of childbearing potential not using any of the following methods
             of birth control (for one month): condom or diaphragm with spermicide, vasectomized
             partner (&gt;6 months), intrauterine device (IUD), abstinence;

          -  Female participants who were breast-feeding.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Merck Sharp &amp; Dohme Corp.</affiliation>
  </overall_official>
  <removed_countries>
    <country>Austria</country>
    <country>Denmark</country>
    <country>Germany</country>
  </removed_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 25, 2007</study_first_submitted>
  <study_first_submitted_qc>September 25, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2007</study_first_posted>
  <results_first_submitted>September 6, 2018</results_first_submitted>
  <results_first_submitted_qc>September 6, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">February 11, 2019</results_first_posted>
  <last_update_submitted>September 6, 2018</last_update_submitted>
  <last_update_submitted_qc>September 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bromides</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>https://www.merck.com/clinical-trials/pdf/ProcedureAccessClinicalTrialData.pdf</ipd_description>
    <ipd_url>http://engagezone.msd.com/ds_documentation.php</ipd_url>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>CSR Synopsis</doc_type>
      <doc_url>http://www.merck.com/clinical-trials/policies-perspectives.html</doc_url>
    </study_doc>
  </study_docs>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Of the N=174 randomized participants, N=173 received treatment. Treated participants are counted as Started in the arm that most accurately describes the treatment received. If no treatment was received (N=1 participant), participants are counted as Started in the arm to which they were randomized.</recruitment_details>
      <pre_assignment_details>N=2 participants (randomized to Arm O) received (rec’d) 8 mg/kg Sugammadex, 3 minutes (min) after 1.2 mg/kg Esmeron® and are counted as Started/Treated in Arm P. Further, N=1 participant (randomized to Arm Q) rec’d 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron® and is counted as Started/Treated in Arm W.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Arm A. Placebo; 3 Min After 1 mg/kg Esmeron®</title>
          <description>Placebo (single intravenous (IV) bolus) administered 3 minutes (min) after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P2">
          <title>Arm B. 2 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (2 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P3">
          <title>Arm C. 4 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (4 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P4">
          <title>Arm D. 8 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (8 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P5">
          <title>Arm E. 12 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (12 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P6">
          <title>Arm F. 16 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (16 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P7">
          <title>Arm G. Placebo; 15 Min After 1 mg/kg Esmeron®</title>
          <description>Placebo (single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P8">
          <title>Arm H. 2 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (2 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P9">
          <title>Arm I. 4 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (4 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P10">
          <title>Arm J. 8 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (8 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P11">
          <title>Arm K. 12 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (12 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P12">
          <title>Arm L. 16 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (16 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P13">
          <title>Arm M. Placebo; 3 Min After 1.2 mg/kg Esmeron®</title>
          <description>Placebo (single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P14">
          <title>Arm N. 2 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (2 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P15">
          <title>Arm O. 4 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (4 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P16">
          <title>Arm P. 8 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (8 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P17">
          <title>Arm Q. 12 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (12 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P18">
          <title>Arm R. 16 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (16 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P19">
          <title>Arm S. Placebo; 15 Min After 1.2 mg/kg Esmeron®</title>
          <description>Placebo (single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P20">
          <title>Arm T. 2 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (2 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P21">
          <title>Arm U. 4 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (4 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P22">
          <title>Arm V. 8 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (8 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P23">
          <title>Arm W. 12 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (12 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="P24">
          <title>Arm X. 16 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (16 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="11"/>
                <participants group_id="P5" count="11"/>
                <participants group_id="P6" count="10"/>
                <participants group_id="P7" count="3"/>
                <participants group_id="P8" count="5"/>
                <participants group_id="P9" count="5"/>
                <participants group_id="P10" count="5"/>
                <participants group_id="P11" count="5"/>
                <participants group_id="P12" count="5"/>
                <participants group_id="P13" count="5"/>
                <participants group_id="P14" count="10"/>
                <participants group_id="P15" count="9"/>
                <participants group_id="P16" count="13">N=11 randomized to Arm P. An additional N=2 (randomized to Arm O) are counted as Started in Arm P</participants>
                <participants group_id="P17" count="10"/>
                <participants group_id="P18" count="11"/>
                <participants group_id="P19" count="3"/>
                <participants group_id="P20" count="5"/>
                <participants group_id="P21" count="5"/>
                <participants group_id="P22" count="5"/>
                <participants group_id="P23" count="6">N=5 randomized to Arm W. An additional N=1 (randomized to Arm Q) is counted as Started in Arm W</participants>
                <participants group_id="P24" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Treated</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="11"/>
                <participants group_id="P5" count="11"/>
                <participants group_id="P6" count="10"/>
                <participants group_id="P7" count="3"/>
                <participants group_id="P8" count="5"/>
                <participants group_id="P9" count="4"/>
                <participants group_id="P10" count="5"/>
                <participants group_id="P11" count="5"/>
                <participants group_id="P12" count="5"/>
                <participants group_id="P13" count="5"/>
                <participants group_id="P14" count="10"/>
                <participants group_id="P15" count="9"/>
                <participants group_id="P16" count="13">N=2 (randomized to Arm O) rec’d 8 mg/kg Sugammadex, 3 min after 1.2 mg/kg Esmeron®</participants>
                <participants group_id="P17" count="10"/>
                <participants group_id="P18" count="11"/>
                <participants group_id="P19" count="3"/>
                <participants group_id="P20" count="5"/>
                <participants group_id="P21" count="5"/>
                <participants group_id="P22" count="5"/>
                <participants group_id="P23" count="6">N=1 (randomized to Arm Q) rec’d 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron®</participants>
                <participants group_id="P24" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="11"/>
                <participants group_id="P5" count="11"/>
                <participants group_id="P6" count="10"/>
                <participants group_id="P7" count="3"/>
                <participants group_id="P8" count="5"/>
                <participants group_id="P9" count="4"/>
                <participants group_id="P10" count="4"/>
                <participants group_id="P11" count="5"/>
                <participants group_id="P12" count="5"/>
                <participants group_id="P13" count="5"/>
                <participants group_id="P14" count="10"/>
                <participants group_id="P15" count="9"/>
                <participants group_id="P16" count="13"/>
                <participants group_id="P17" count="10"/>
                <participants group_id="P18" count="11"/>
                <participants group_id="P19" count="3"/>
                <participants group_id="P20" count="5"/>
                <participants group_id="P21" count="5"/>
                <participants group_id="P22" count="4"/>
                <participants group_id="P23" count="6"/>
                <participants group_id="P24" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="1"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Includes all participants receiving study treatment. N=2 participants (originally randomized to Arm O), rec’d 8 mg/kg sugammadex, 3 min after 1.2 mg/kg Esmeron® (counted in Arm P). N=1 participant (originally randomized to Arm Q) rec’d 12 mg/kg sugammadex, 29min after 1.2 mg/kg Esmeron® (counted in Arm W).</population>
      <group_list>
        <group group_id="B1">
          <title>Arm A. Placebo; 3 Min After 1 mg/kg Esmeron®</title>
          <description>Placebo (single intravenous (IV) bolus) administered 3 minutes (min) after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B2">
          <title>Arm B. 2 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (2 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B3">
          <title>Arm C. 4 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (4 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B4">
          <title>Arm D. 8 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (8 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B5">
          <title>Arm E. 12 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (12 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B6">
          <title>Arm F. 16 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (16 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B7">
          <title>Arm G. Placebo; 15 Min After 1 mg/kg Esmeron®</title>
          <description>Placebo (single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B8">
          <title>Arm H. 2 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (2 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B9">
          <title>Arm I. 4 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (4 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B10">
          <title>Arm J. 8 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (8 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B11">
          <title>Arm K. 12 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (12 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B12">
          <title>Arm L. 16 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
          <description>Sugammadex (16 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B13">
          <title>Arm M. Placebo; 3 Min After 1.2 mg/kg Esmeron®</title>
          <description>Placebo (single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B14">
          <title>Arm N. 2 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (2 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B15">
          <title>Arm O. 4 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (4 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B16">
          <title>Arm P. 8 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (8 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B17">
          <title>Arm Q. 12 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (12 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B18">
          <title>Arm R. 16 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (16 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B19">
          <title>Arm S. Placebo; 15 Min After 1.2 mg/kg Esmeron®</title>
          <description>Placebo (single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B20">
          <title>Arm T. 2 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (2 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B21">
          <title>Arm U. 4 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (4 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B22">
          <title>Arm V. 8 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (8 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B23">
          <title>Arm W. 12 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (12 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B24">
          <title>Arm X. 16 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
          <description>Sugammadex (16 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="B25">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="11"/>
            <count group_id="B4" value="11"/>
            <count group_id="B5" value="11"/>
            <count group_id="B6" value="10"/>
            <count group_id="B7" value="3"/>
            <count group_id="B8" value="5"/>
            <count group_id="B9" value="4"/>
            <count group_id="B10" value="5"/>
            <count group_id="B11" value="5"/>
            <count group_id="B12" value="5"/>
            <count group_id="B13" value="5"/>
            <count group_id="B14" value="10"/>
            <count group_id="B15" value="9"/>
            <count group_id="B16" value="13"/>
            <count group_id="B17" value="10"/>
            <count group_id="B18" value="11"/>
            <count group_id="B19" value="3"/>
            <count group_id="B20" value="5"/>
            <count group_id="B21" value="5"/>
            <count group_id="B22" value="5"/>
            <count group_id="B23" value="6"/>
            <count group_id="B24" value="5"/>
            <count group_id="B25" value="173"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>Includes all participants receiving study treatment. N=2 participants (originally randomized to Arm O), rec’d 8 mg/kg sugammadex, 3 min after 1.2 mg/kg Esmeron® (counted in Arm P). N=1 participant (originally randomized to Arm Q) rec’d 12 mg/kg sugammadex, 29min after 1.2 mg/kg Esmeron® (counted in Arm W).</population>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.8" spread="16.0"/>
                    <measurement group_id="B2" value="45.8" spread="17.9"/>
                    <measurement group_id="B3" value="48.4" spread="16.3"/>
                    <measurement group_id="B4" value="46.8" spread="11.3"/>
                    <measurement group_id="B5" value="47.5" spread="12.8"/>
                    <measurement group_id="B6" value="54.9" spread="17.5"/>
                    <measurement group_id="B7" value="43.3" spread="5.7"/>
                    <measurement group_id="B8" value="51.2" spread="18.9"/>
                    <measurement group_id="B9" value="63.0" spread="6.2"/>
                    <measurement group_id="B10" value="45.2" spread="17.3"/>
                    <measurement group_id="B11" value="56.0" spread="8.9"/>
                    <measurement group_id="B12" value="62.4" spread="7.9"/>
                    <measurement group_id="B13" value="57.2" spread="13.2"/>
                    <measurement group_id="B14" value="53.0" spread="16.2"/>
                    <measurement group_id="B15" value="47.9" spread="21.1"/>
                    <measurement group_id="B16" value="52.6" spread="12.6"/>
                    <measurement group_id="B17" value="57.5" spread="14.6"/>
                    <measurement group_id="B18" value="48.7" spread="15.4"/>
                    <measurement group_id="B19" value="48.0" spread="28.0"/>
                    <measurement group_id="B20" value="41.8" spread="21.3"/>
                    <measurement group_id="B21" value="45.0" spread="17.0"/>
                    <measurement group_id="B22" value="44.8" spread="19.8"/>
                    <measurement group_id="B23" value="51.8" spread="10.3"/>
                    <measurement group_id="B24" value="46.0" spread="22.4"/>
                    <measurement group_id="B25" value="50.4" spread="15.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>Includes all participants receiving study treatment. N=2 participants (originally randomized to Arm O), rec’d 8 mg/kg sugammadex, 3 min after 1.2 mg/kg Esmeron® (counted in Arm P). N=1 participant (originally randomized to Arm Q) rec’d 12 mg/kg sugammadex, 29min after 1.2 mg/kg Esmeron® (counted in Arm W).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="7"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="2"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="1"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="5"/>
                    <measurement group_id="B13" value="4"/>
                    <measurement group_id="B14" value="6"/>
                    <measurement group_id="B15" value="6"/>
                    <measurement group_id="B16" value="3"/>
                    <measurement group_id="B17" value="4"/>
                    <measurement group_id="B18" value="6"/>
                    <measurement group_id="B19" value="2"/>
                    <measurement group_id="B20" value="1"/>
                    <measurement group_id="B21" value="2"/>
                    <measurement group_id="B22" value="1"/>
                    <measurement group_id="B23" value="1"/>
                    <measurement group_id="B24" value="4"/>
                    <measurement group_id="B25" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="6"/>
                    <measurement group_id="B6" value="3"/>
                    <measurement group_id="B7" value="3"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="4"/>
                    <measurement group_id="B10" value="4"/>
                    <measurement group_id="B11" value="4"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="1"/>
                    <measurement group_id="B14" value="4"/>
                    <measurement group_id="B15" value="3"/>
                    <measurement group_id="B16" value="10"/>
                    <measurement group_id="B17" value="6"/>
                    <measurement group_id="B18" value="5"/>
                    <measurement group_id="B19" value="1"/>
                    <measurement group_id="B20" value="4"/>
                    <measurement group_id="B21" value="3"/>
                    <measurement group_id="B22" value="4"/>
                    <measurement group_id="B23" value="5"/>
                    <measurement group_id="B24" value="1"/>
                    <measurement group_id="B25" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <population>Includes all participants receiving study treatment. N=2 participants (originally randomized to Arm O), rec’d 8 mg/kg sugammadex, 3 min after 1.2 mg/kg Esmeron® (counted in Arm P). N=1 participant (originally randomized to Arm Q) rec’d 12 mg/kg sugammadex, 29min after 1.2 mg/kg Esmeron® (counted in Arm W).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="11"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="10"/>
                    <measurement group_id="B7" value="3"/>
                    <measurement group_id="B8" value="5"/>
                    <measurement group_id="B9" value="4"/>
                    <measurement group_id="B10" value="5"/>
                    <measurement group_id="B11" value="5"/>
                    <measurement group_id="B12" value="5"/>
                    <measurement group_id="B13" value="5"/>
                    <measurement group_id="B14" value="10"/>
                    <measurement group_id="B15" value="9"/>
                    <measurement group_id="B16" value="13"/>
                    <measurement group_id="B17" value="10"/>
                    <measurement group_id="B18" value="11"/>
                    <measurement group_id="B19" value="3"/>
                    <measurement group_id="B20" value="5"/>
                    <measurement group_id="B21" value="5"/>
                    <measurement group_id="B22" value="5"/>
                    <measurement group_id="B23" value="5"/>
                    <measurement group_id="B24" value="5"/>
                    <measurement group_id="B25" value="171"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="1"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Time From Start of Study Treatment Administration to Recovery of the T4/T1 Ratio to 0.9</title>
        <description>Mean time from start of study treatment administration to recovery of participant T4/T1 ratio to 0.9 was assessed through the repeated application (every 15 seconds) of an electrical stimulation protocol. Specifically, 4 electrical stimulations were applied to the ulnar nerve and the magnitude of the twitch response of the adductor pollicis muscle (i.e. thumb twitch response) was assessed. With T4 and T1 referring to the respective magnitude of the fourth and first thumb twitch during nerve stimulation, the T4/T1 ratio indicates the current degree of neuromuscular blockade (NMB) present in the participant as a decimal from 0 (loss of T4 twitch) to 1 (no NMB). Further, reduced recovery time of the T4/T1 ratio to 0.9 indicates faster recovery from NMB. Summary data, originally presented in the format of units &quot;minutes:seconds&quot; (mm:ss), was reformatted to be presented in the single unit of &quot;minutes&quot; (min).</description>
        <time_frame>Up to 240 minutes following administration of study treatment</time_frame>
        <population>Includes all participants receiving study treatment, having ≥1 post-baseline observation without a major protocol violation. Additionally, N=1 participant was excluded from Arm M due to missing data and N=1 participant was excluded from Arm N due to unreliability of the neuromuscular data.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A. Placebo; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Placebo (single intravenous (IV) bolus) administered 3 minutes (min) after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O2">
            <title>Arm B. 2 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (2 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O3">
            <title>Arm C. 4 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (4 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O4">
            <title>Arm D. 8 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (8 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O5">
            <title>Arm E. 12 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (12 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O6">
            <title>Arm F. 16 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (16 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O7">
            <title>Arm G. Placebo; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Placebo (single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O8">
            <title>Arm H. 2 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (2 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O9">
            <title>Arm I. 4 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (4 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O10">
            <title>Arm J. 8 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (8 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O11">
            <title>Arm K. 12 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (12 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O12">
            <title>Arm L. 16 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (16 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O13">
            <title>Arm M. Placebo; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Placebo (single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O14">
            <title>Arm N. 2 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (2 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O15">
            <title>Arm O. 4 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (4 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O16">
            <title>Arm P. 8 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (8 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O17">
            <title>Arm Q. 12 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (12 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O18">
            <title>Arm R. 16 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (16 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O19">
            <title>Arm S. Placebo; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Placebo (single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O20">
            <title>Arm T. 2 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (2 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O21">
            <title>Arm U. 4 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (4 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O22">
            <title>Arm V. 8 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (8 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O23">
            <title>Arm W. 12 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (12 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O24">
            <title>Arm X. 16 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (16 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Time From Start of Study Treatment Administration to Recovery of the T4/T1 Ratio to 0.9</title>
          <description>Mean time from start of study treatment administration to recovery of participant T4/T1 ratio to 0.9 was assessed through the repeated application (every 15 seconds) of an electrical stimulation protocol. Specifically, 4 electrical stimulations were applied to the ulnar nerve and the magnitude of the twitch response of the adductor pollicis muscle (i.e. thumb twitch response) was assessed. With T4 and T1 referring to the respective magnitude of the fourth and first thumb twitch during nerve stimulation, the T4/T1 ratio indicates the current degree of neuromuscular blockade (NMB) present in the participant as a decimal from 0 (loss of T4 twitch) to 1 (no NMB). Further, reduced recovery time of the T4/T1 ratio to 0.9 indicates faster recovery from NMB. Summary data, originally presented in the format of units &quot;minutes:seconds&quot; (mm:ss), was reformatted to be presented in the single unit of &quot;minutes&quot; (min).</description>
          <population>Includes all participants receiving study treatment, having ≥1 post-baseline observation without a major protocol violation. Additionally, N=1 participant was excluded from Arm M due to missing data and N=1 participant was excluded from Arm N due to unreliability of the neuromuscular data.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="11"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="11"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="5"/>
                <count group_id="O9" value="4"/>
                <count group_id="O10" value="5"/>
                <count group_id="O11" value="5"/>
                <count group_id="O12" value="5"/>
                <count group_id="O13" value="4"/>
                <count group_id="O14" value="9"/>
                <count group_id="O15" value="8"/>
                <count group_id="O16" value="11"/>
                <count group_id="O17" value="10"/>
                <count group_id="O18" value="11"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="5"/>
                <count group_id="O21" value="5"/>
                <count group_id="O22" value="5"/>
                <count group_id="O23" value="5"/>
                <count group_id="O24" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="108.43" spread="31.17"/>
                    <measurement group_id="O2" value="44.73" spread="22.18"/>
                    <measurement group_id="O3" value="6.93" spread="2.87"/>
                    <measurement group_id="O4" value="2.40" spread="1.17"/>
                    <measurement group_id="O5" value="2.42" spread="2.12"/>
                    <measurement group_id="O6" value="1.77" spread="1.13"/>
                    <measurement group_id="O7" value="127.37" spread="92.77"/>
                    <measurement group_id="O8" value="8.53" spread="1.12"/>
                    <measurement group_id="O9" value="5.47" spread="3.13"/>
                    <measurement group_id="O10" value="1.85" spread="0.55"/>
                    <measurement group_id="O11" value="1.78" spread="0.87"/>
                    <measurement group_id="O12" value="0.93" spread="0.13"/>
                    <measurement group_id="O13" value="122.98" spread="28.47"/>
                    <measurement group_id="O14" value="65.67" spread="24.58"/>
                    <measurement group_id="O15" value="13.78" spread="7.63"/>
                    <measurement group_id="O16" value="3.23" spread="0.98"/>
                    <measurement group_id="O17" value="2.08" spread="0.85"/>
                    <measurement group_id="O18" value="1.32" spread="0.42"/>
                    <measurement group_id="O19" value="139.62" spread="79.88"/>
                    <measurement group_id="O20" value="42.20" spread="29.33"/>
                    <measurement group_id="O21" value="5.97" spread="2.47"/>
                    <measurement group_id="O22" value="2.33" spread="0.30"/>
                    <measurement group_id="O23" value="1.77" spread="1.18"/>
                    <measurement group_id="O24" value="4.73" spread="6.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Time From Start of Study Treatment Administration to Recovery of the T4/T1 Ratio to 0.8</title>
        <description>Mean time from start of study treatment administration to recovery of participant T4/T1 ratio to 0.8 was assessed through the repeated application (every 15 seconds) of an electrical stimulation protocol. Specifically, 4 electrical stimulations were applied to the ulnar nerve and the magnitude of the twitch response of the adductor pollicis muscle (i.e. thumb twitch response) was assessed. With T4 and T1 referring to the respective magnitude of the fourth and first thumb twitch during nerve stimulation, the T4/T1 ratio indicates the current degree of NMB present in the participant as a decimal from 0 (loss of T4 twitch) to 1 (no NMB). Further, reduced recovery time of the T4/T1 ratio to 0.8 indicates faster recovery from NMB. Summary data, originally presented in the format of units &quot;minutes:seconds&quot; (mm:ss), was reformatted to be presented in the single unit of &quot;minutes&quot; (min).</description>
        <time_frame>Up to 200 minutes following administration of study treatment</time_frame>
        <population>Includes all participants receiving study treatment, having ≥1 post-baseline observation without a major protocol violation.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A. Placebo; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Placebo (single intravenous (IV) bolus) administered 3 minutes (min) after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O2">
            <title>Arm B. 2 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (2 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O3">
            <title>Arm C. 4 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (4 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O4">
            <title>Arm D. 8 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (8 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O5">
            <title>Arm E. 12 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (12 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O6">
            <title>Arm F. 16 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (16 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O7">
            <title>Arm G. Placebo; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Placebo (single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O8">
            <title>Arm H. 2 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (2 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O9">
            <title>Arm I. 4 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (4 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O10">
            <title>Arm J. 8 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (8 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O11">
            <title>Arm K. 12 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (12 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O12">
            <title>Arm L. 16 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (16 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O13">
            <title>Arm M. Placebo; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Placebo (single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O14">
            <title>Arm N. 2 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (2 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O15">
            <title>Arm O. 4 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (4 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O16">
            <title>Arm P. 8 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (8 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O17">
            <title>Arm Q. 12 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (12 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O18">
            <title>Arm R. 16 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (16 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O19">
            <title>Arm S. Placebo; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Placebo (single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O20">
            <title>Arm T. 2 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (2 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O21">
            <title>Arm U. 4 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (4 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O22">
            <title>Arm V. 8 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (8 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O23">
            <title>Arm W. 12 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (12 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O24">
            <title>Arm X. 16 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (16 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Time From Start of Study Treatment Administration to Recovery of the T4/T1 Ratio to 0.8</title>
          <description>Mean time from start of study treatment administration to recovery of participant T4/T1 ratio to 0.8 was assessed through the repeated application (every 15 seconds) of an electrical stimulation protocol. Specifically, 4 electrical stimulations were applied to the ulnar nerve and the magnitude of the twitch response of the adductor pollicis muscle (i.e. thumb twitch response) was assessed. With T4 and T1 referring to the respective magnitude of the fourth and first thumb twitch during nerve stimulation, the T4/T1 ratio indicates the current degree of NMB present in the participant as a decimal from 0 (loss of T4 twitch) to 1 (no NMB). Further, reduced recovery time of the T4/T1 ratio to 0.8 indicates faster recovery from NMB. Summary data, originally presented in the format of units &quot;minutes:seconds&quot; (mm:ss), was reformatted to be presented in the single unit of &quot;minutes&quot; (min).</description>
          <population>Includes all participants receiving study treatment, having ≥1 post-baseline observation without a major protocol violation.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="11"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="11"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="5"/>
                <count group_id="O9" value="4"/>
                <count group_id="O10" value="5"/>
                <count group_id="O11" value="5"/>
                <count group_id="O12" value="5"/>
                <count group_id="O13" value="5"/>
                <count group_id="O14" value="10"/>
                <count group_id="O15" value="8"/>
                <count group_id="O16" value="11"/>
                <count group_id="O17" value="10"/>
                <count group_id="O18" value="11"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="5"/>
                <count group_id="O21" value="5"/>
                <count group_id="O22" value="5"/>
                <count group_id="O23" value="5"/>
                <count group_id="O24" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.23" spread="28.82"/>
                    <measurement group_id="O2" value="40.00" spread="20.47"/>
                    <measurement group_id="O3" value="5.90" spread="2.40"/>
                    <measurement group_id="O4" value="1.87" spread="0.73"/>
                    <measurement group_id="O5" value="1.57" spread="1.35"/>
                    <measurement group_id="O6" value="1.43" spread="0.97"/>
                    <measurement group_id="O7" value="91.53" spread="43.73"/>
                    <measurement group_id="O8" value="6.23" spread="1.23"/>
                    <measurement group_id="O9" value="4.10" spread="2.60"/>
                    <measurement group_id="O10" value="1.45" spread="0.43"/>
                    <measurement group_id="O11" value="1.33" spread="0.50"/>
                    <measurement group_id="O12" value="0.93" spread="0.13"/>
                    <measurement group_id="O13" value="129.85" spread="39.48"/>
                    <measurement group_id="O14" value="60.85" spread="21.13"/>
                    <measurement group_id="O15" value="8.52" spread="2.80"/>
                    <measurement group_id="O16" value="2.80" spread="1.02"/>
                    <measurement group_id="O17" value="1.73" spread="0.82"/>
                    <measurement group_id="O18" value="1.20" spread="0.27"/>
                    <measurement group_id="O19" value="121.03" spread="63.07"/>
                    <measurement group_id="O20" value="33.95" spread="23.02"/>
                    <measurement group_id="O21" value="4.42" spread="1.38"/>
                    <measurement group_id="O22" value="1.98" spread="0.27"/>
                    <measurement group_id="O23" value="1.72" spread="1.07"/>
                    <measurement group_id="O24" value="1.27" spread="0.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Time From Start of Study Treatment Administration to Recovery of the T4/T1 Ratio to 0.7</title>
        <description>Mean time from start of study treatment administration to recovery of participant T4/T1 ratio to 0.7 was assessed through the repeated application (every 15 seconds) of an electrical stimulation protocol. Specifically, 4 electrical stimulations were applied to the ulnar nerve and the magnitude of the twitch response of the adductor pollicis muscle (i.e. thumb twitch response) was assessed. With T4 and T1 referring to the respective magnitude of the fourth and first thumb twitch during nerve stimulation, the T4/T1 ratio indicates the current degree of NMB present in the participant as a decimal from 0 (loss of T4 twitch) to 1 (no NMB). Further, reduced recovery time of the T4/T1 ratio to 0.7 indicates faster recovery from NMB. Summary data, originally presented in the format of units &quot;minutes:seconds&quot; (mm:ss), was reformatted to be presented in the single unit of &quot;minutes&quot; (min).</description>
        <time_frame>Up to 180 minutes following administration of study treatment</time_frame>
        <population>Includes all participants receiving study treatment, having ≥1 post-baseline observation without a major protocol violation.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A. Placebo; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Placebo (single intravenous (IV) bolus) administered 3 minutes (min) after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O2">
            <title>Arm B. 2 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (2 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O3">
            <title>Arm C. 4 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (4 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O4">
            <title>Arm D. 8 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (8 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O5">
            <title>Arm E. 12 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (12 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O6">
            <title>Arm F. 16 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (16 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O7">
            <title>Arm G. Placebo; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Placebo (single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O8">
            <title>Arm H. 2 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (2 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O9">
            <title>Arm I. 4 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (4 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O10">
            <title>Arm J. 8 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (8 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O11">
            <title>Arm K. 12 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (12 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O12">
            <title>Arm L. 16 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (16 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O13">
            <title>Arm M. Placebo; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Placebo (single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O14">
            <title>Arm N. 2 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (2 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O15">
            <title>Arm O. 4 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (4 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O16">
            <title>Arm P. 8 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (8 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O17">
            <title>Arm Q. 12 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (12 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O18">
            <title>Arm R. 16 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (16 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O19">
            <title>Arm S. Placebo; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Placebo (single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O20">
            <title>Arm T. 2 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (2 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O21">
            <title>Arm U. 4 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (4 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O22">
            <title>Arm V. 8 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (8 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O23">
            <title>Arm W. 12 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (12 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O24">
            <title>Arm X. 16 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (16 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Time From Start of Study Treatment Administration to Recovery of the T4/T1 Ratio to 0.7</title>
          <description>Mean time from start of study treatment administration to recovery of participant T4/T1 ratio to 0.7 was assessed through the repeated application (every 15 seconds) of an electrical stimulation protocol. Specifically, 4 electrical stimulations were applied to the ulnar nerve and the magnitude of the twitch response of the adductor pollicis muscle (i.e. thumb twitch response) was assessed. With T4 and T1 referring to the respective magnitude of the fourth and first thumb twitch during nerve stimulation, the T4/T1 ratio indicates the current degree of NMB present in the participant as a decimal from 0 (loss of T4 twitch) to 1 (no NMB). Further, reduced recovery time of the T4/T1 ratio to 0.7 indicates faster recovery from NMB. Summary data, originally presented in the format of units &quot;minutes:seconds&quot; (mm:ss), was reformatted to be presented in the single unit of &quot;minutes&quot; (min).</description>
          <population>Includes all participants receiving study treatment, having ≥1 post-baseline observation without a major protocol violation.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="11"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="11"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="5"/>
                <count group_id="O9" value="4"/>
                <count group_id="O10" value="5"/>
                <count group_id="O11" value="5"/>
                <count group_id="O12" value="5"/>
                <count group_id="O13" value="5"/>
                <count group_id="O14" value="10"/>
                <count group_id="O15" value="8"/>
                <count group_id="O16" value="11"/>
                <count group_id="O17" value="10"/>
                <count group_id="O18" value="11"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="5"/>
                <count group_id="O21" value="5"/>
                <count group_id="O22" value="5"/>
                <count group_id="O23" value="5"/>
                <count group_id="O24" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.58" spread="27.43"/>
                    <measurement group_id="O2" value="36.43" spread="17.22"/>
                    <measurement group_id="O3" value="4.55" spread="1.43"/>
                    <measurement group_id="O4" value="1.58" spread="0.70"/>
                    <measurement group_id="O5" value="1.13" spread="0.12"/>
                    <measurement group_id="O6" value="1.27" spread="0.52"/>
                    <measurement group_id="O7" value="81.70" spread="34.18"/>
                    <measurement group_id="O8" value="5.28" spread="0.77"/>
                    <measurement group_id="O9" value="3.28" spread="1.62"/>
                    <measurement group_id="O10" value="1.25" spread="0.15"/>
                    <measurement group_id="O11" value="1.28" spread="0.42"/>
                    <measurement group_id="O12" value="0.93" spread="0.13"/>
                    <measurement group_id="O13" value="122.90" spread="36.23"/>
                    <measurement group_id="O14" value="54.43" spread="17.33"/>
                    <measurement group_id="O15" value="7.45" spread="2.82"/>
                    <measurement group_id="O16" value="2.42" spread="0.85"/>
                    <measurement group_id="O17" value="1.62" spread="0.80"/>
                    <measurement group_id="O18" value="1.18" spread="0.22"/>
                    <measurement group_id="O19" value="111.37" spread="53.03"/>
                    <measurement group_id="O20" value="24.15" spread="13.00"/>
                    <measurement group_id="O21" value="3.08" spread="0.90"/>
                    <measurement group_id="O22" value="1.58" spread="0.35"/>
                    <measurement group_id="O23" value="1.67" spread="0.97"/>
                    <measurement group_id="O24" value="1.22" spread="0.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Experiencing an Adverse Event</title>
        <description>The number of participants experiencing an adverse event (AE) was assessed. An AE was defined as any untoward medical occurrence in a participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of an investigational product, whether or not considered related to the investigational product.</description>
        <time_frame>Up to 7 days following administration of study treatment</time_frame>
        <population>Includes all participants receiving study treatment. N=2 participants (originally randomized to Arm O), rec’d 8 mg/kg sugammadex, 3 min after 1.2 mg/kg Esmeron® (counted in Arm P). N=1 participant (originally randomized to Arm Q) rec’d 12 mg/kg sugammadex, 29min after 1.2 mg/kg Esmeron® (counted in Arm W).</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A. Placebo; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Placebo (single intravenous (IV) bolus) administered 3 minutes (min) after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O2">
            <title>Arm B. 2 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (2 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O3">
            <title>Arm C. 4 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (4 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O4">
            <title>Arm D. 8 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (8 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O5">
            <title>Arm E. 12 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (12 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O6">
            <title>Arm F. 16 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (16 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O7">
            <title>Arm G. Placebo; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Placebo (single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O8">
            <title>Arm H. 2 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (2 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O9">
            <title>Arm I. 4 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (4 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O10">
            <title>Arm J. 8 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (8 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O11">
            <title>Arm K. 12 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (12 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O12">
            <title>Arm L. 16 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron®</title>
            <description>Sugammadex (16 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O13">
            <title>Arm M. Placebo; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Placebo (single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O14">
            <title>Arm N. 2 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (2 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O15">
            <title>Arm O. 4 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (4 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O16">
            <title>Arm P. 8 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (8 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O17">
            <title>Arm Q. 12 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (12 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O18">
            <title>Arm R. 16 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (16 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O19">
            <title>Arm S. Placebo; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Placebo (single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O20">
            <title>Arm T. 2 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (2 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O21">
            <title>Arm U. 4 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (4 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O22">
            <title>Arm V. 8 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (8 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O23">
            <title>Arm W. 12 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (12 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
          <group group_id="O24">
            <title>Arm X. 16 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron®</title>
            <description>Sugammadex (16 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Experiencing an Adverse Event</title>
          <description>The number of participants experiencing an adverse event (AE) was assessed. An AE was defined as any untoward medical occurrence in a participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of an investigational product, whether or not considered related to the investigational product.</description>
          <population>Includes all participants receiving study treatment. N=2 participants (originally randomized to Arm O), rec’d 8 mg/kg sugammadex, 3 min after 1.2 mg/kg Esmeron® (counted in Arm P). N=1 participant (originally randomized to Arm Q) rec’d 12 mg/kg sugammadex, 29min after 1.2 mg/kg Esmeron® (counted in Arm W).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="11"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="11"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="5"/>
                <count group_id="O9" value="4"/>
                <count group_id="O10" value="5"/>
                <count group_id="O11" value="5"/>
                <count group_id="O12" value="5"/>
                <count group_id="O13" value="5"/>
                <count group_id="O14" value="10"/>
                <count group_id="O15" value="9"/>
                <count group_id="O16" value="13"/>
                <count group_id="O17" value="10"/>
                <count group_id="O18" value="11"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="5"/>
                <count group_id="O21" value="5"/>
                <count group_id="O22" value="5"/>
                <count group_id="O23" value="6"/>
                <count group_id="O24" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="4"/>
                    <measurement group_id="O13" value="3"/>
                    <measurement group_id="O14" value="5"/>
                    <measurement group_id="O15" value="7"/>
                    <measurement group_id="O16" value="5"/>
                    <measurement group_id="O17" value="6"/>
                    <measurement group_id="O18" value="9"/>
                    <measurement group_id="O19" value="3"/>
                    <measurement group_id="O20" value="2"/>
                    <measurement group_id="O21" value="4"/>
                    <measurement group_id="O22" value="1"/>
                    <measurement group_id="O23" value="3"/>
                    <measurement group_id="O24" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 7 days following administration of study treatment</time_frame>
      <desc>Includes all participants receiving study treatment. N=2 participants (originally randomized to Arm O), rec’d 8 mg/kg sugammadex, 3 min after 1.2 mg/kg Esmeron® (counted in Arm P). N=1 participant (originally randomized to Arm Q) rec’d 12 mg/kg sugammadex, 29min after 1.2 mg/kg Esmeron® (counted in Arm W).</desc>
      <group_list>
        <group group_id="E1">
          <title>Arm A. Placebo; 3 Min After 1 mg/kg Esmeron</title>
          <description>Placebo (single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E2">
          <title>Arm B. 2 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron</title>
          <description>Sugammadex (2 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E3">
          <title>Arm C. 4 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron</title>
          <description>Sugammadex (4 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E4">
          <title>Arm D. 8 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron</title>
          <description>Sugammadex (8 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E5">
          <title>Arm E. 12 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron</title>
          <description>Sugammadex (12 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E6">
          <title>Arm F. 16 mg/kg Sugammadex; 3 Min After 1 mg/kg Esmeron</title>
          <description>Sugammadex (16 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E7">
          <title>Arm G. Placebo; 15 Min After 1 mg/kg Esmeron</title>
          <description>Placebo (single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E8">
          <title>Arm H. 2 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron</title>
          <description>Sugammadex (2 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E9">
          <title>Arm I. 4 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron</title>
          <description>Sugammadex (4 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E10">
          <title>Arm J. 8 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron</title>
          <description>Sugammadex (8 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E11">
          <title>Arm K. 12 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron</title>
          <description>Sugammadex (12 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E12">
          <title>Arm L. 16 mg/kg Sugammadex; 15 Min After 1 mg/kg Esmeron</title>
          <description>Sugammadex (16 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E13">
          <title>Arm M. Placebo; 3 Min After 1.2 mg/kg Esmeron</title>
          <description>Placebo (single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E14">
          <title>Arm N. 2 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron</title>
          <description>Sugammadex (2 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E15">
          <title>Arm O. 4 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron</title>
          <description>Sugammadex (4 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E16">
          <title>Arm P. 8 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron</title>
          <description>Sugammadex (8 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E17">
          <title>Arm Q. 12 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron</title>
          <description>Sugammadex (12 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E18">
          <title>Arm R. 16 mg/kg Sugammadex; 3 Min After 1.2 mg/kg Esmeron</title>
          <description>Sugammadex (16 mg/kg; single IV bolus) administered 3 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E19">
          <title>Arm S. Placebo; 15 Min After 1.2 mg/kg Esmeron</title>
          <description>Placebo (single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E20">
          <title>Arm T. 2 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron</title>
          <description>Sugammadex (2 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E21">
          <title>Arm U. 4 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron</title>
          <description>Sugammadex (4 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E22">
          <title>Arm V. 8 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron</title>
          <description>Sugammadex (8 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E23">
          <title>Arm W. 12 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron</title>
          <description>Sugammadex (12 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
        <group group_id="E24">
          <title>Arm X. 16 mg/kg Sugammadex; 15 Min After 1.2 mg/kg Esmeron</title>
          <description>Sugammadex (16 mg/kg; single IV bolus) administered 15 min after the bolus intubation dose of 1.2 mg/kg Esmeron®.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 7.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Electrocardiogram QT corrected interval prolonged</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="3" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 7.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="11"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="5"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E10" subjects_affected="4" subjects_at_risk="5"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E12" subjects_affected="4" subjects_at_risk="5"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="7" subjects_at_risk="9"/>
                <counts group_id="E16" subjects_affected="5" subjects_at_risk="13"/>
                <counts group_id="E17" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E18" subjects_affected="9" subjects_at_risk="11"/>
                <counts group_id="E19" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E21" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E23" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E24" subjects_affected="3" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Eye irritation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" events="4" subjects_affected="4" subjects_at_risk="9"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="2" subjects_affected="2" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E4" events="4" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="4" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Infusion site erythema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="3" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Airway complication of anaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Anaesthetic complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E4" events="4" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E5" events="4" subjects_affected="4" subjects_at_risk="11"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E9" events="3" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" events="2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E16" events="3" subjects_affected="2" subjects_at_risk="13"/>
                <counts group_id="E17" events="3" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E18" events="7" subjects_affected="5" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="2" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Delayed recovery from anaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Periorbital haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Post procedural pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Procedural hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Procedural hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Heart rate decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Red blood cell count decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Restlessness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Oliguria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hiccups</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pharyngolaryngeal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="1" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Swelling face</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hot flush</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" events="2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E23" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Sponsor recognizes the right of the investigators to publish, but all publications must be based on data validated and released by the Sponsor. Any such scientific paper, presentation, or other communication concerning the clinical trial described in this protocol will first be submitted to the Sponsor, at least six weeks ahead of estimated publication or presentation, for written consent, which shall not be withheld unreasonably.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Senior Vice President, Global Clinical Development</name_or_title>
      <organization>Merck Sharp &amp; Dohme Corp.</organization>
      <phone>1-800-672-6372</phone>
      <email>ClinicalTrialsDisclosure@merck.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

